DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C1261470 | Congenital meningocele | GMPPB | 29925 | GDP-mannose pyrophosphorylase B | Q9Y5P6 |
C0024117 | Chronic Obstructive Airway Disease | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0268275 | Tay-Sachs Disease, AB Variant | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0003467 | Anxiety | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0268274 | Gangliosidoses, GM2 | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0036572 | Seizures | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0026847 | Spinal Muscular Atrophy | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0006142 | Malignant neoplasm of breast | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0235946 | Cerebral atrophy | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C1442826 | Neonatal necrotizing enterocolitis | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0877024 | Schimke immunoosseous dysplasia | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0700345 | Candidiasis, Vulvovaginal | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0524851 | Neurodegenerative Disorders | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0008489 | Chorea | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0497327 | Dementia | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0036161 | Sandhoff Disease | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C4082937 | Necrotizing enterocolitis in fetus OR newborn | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0456909 | Blindness | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0001973 | Alcoholic Intoxication, Chronic | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C1306459 | Primary malignant neoplasm | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0206695 | Carcinoma, Neuroendocrine | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0039373 | Tay-Sachs Disease | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0678222 | Breast Carcinoma | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0013421 | Dystonia | GM2A | 2760 | GM2 ganglioside activator | P17900 |
C0035309 | Retinal Diseases | GM2A | 2760 | GM2 ganglioside activator | P17900 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024